Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection

Although the COVID-19 pandemic began over three years ago, the virus responsible for the disease, SARS-CoV-2, continues to infect people across the globe. As such, there remains a critical need for development of novel therapeutics against SARS-CoV-2. One technology that has remained relatively unex...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yuanyuan, Wotring, Jesse W., Zhang, Charles J., Jiang, Xia, Xiao, Lanbo, Watt, Andy, Gattis, Danielle, Scandalis, Eli, Freier, Susan, Zheng, Yang, Pretto, Carla D., Ellison, Stephanie J., Swayze, Eric E., Guo, Shuling, Sexton, Jonathan Z., Chinnaiyan, Arul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897518/
https://www.ncbi.nlm.nih.gov/pubmed/36735698
http://dx.doi.org/10.1371/journal.pone.0281281

Ejemplares similares

Ejemplares similares